Knowledge Leaders Capital LLC Sells 228 Shares of Danaher Co. (NYSE:DHR)

Knowledge Leaders Capital LLC trimmed its position in Danaher Co. (NYSE:DHR) by 3.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,248 shares of the conglomerate’s stock after selling 228 shares during the period. Danaher makes up approximately 2.3% of Knowledge Leaders Capital LLC’s holdings, making the stock its 15th biggest holding. Knowledge Leaders Capital LLC’s holdings in Danaher were worth $1,445,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Nicholas Hoffman & Company LLC. boosted its stake in Danaher by 2.3% in the fourth quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock valued at $439,000 after acquiring an additional 43 shares in the last quarter. Drive Wealth Management LLC raised its holdings in shares of Danaher by 3.1% in the fourth quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock worth $344,000 after buying an additional 44 shares during the last quarter. Trust Investment Advisors raised its holdings in shares of Danaher by 1.8% in the fourth quarter. Trust Investment Advisors now owns 2,811 shares of the conglomerate’s stock worth $650,000 after buying an additional 49 shares during the last quarter. Connolly Sarah T. raised its holdings in shares of Danaher by 0.5% in the third quarter. Connolly Sarah T. now owns 9,599 shares of the conglomerate’s stock worth $2,382,000 after buying an additional 50 shares during the last quarter. Finally, Austin Private Wealth LLC raised its holdings in shares of Danaher by 3.4% in the third quarter. Austin Private Wealth LLC now owns 1,566 shares of the conglomerate’s stock worth $389,000 after buying an additional 51 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

DHR traded up $0.78 on Friday, reaching $246.58. The stock had a trading volume of 2,710,446 shares, compared to its average volume of 2,710,897. Danaher Co. has a 12-month low of $182.09 and a 12-month high of $259.00. The company has a current ratio of 1.85, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31. The business’s 50-day moving average price is $248.87 and its two-hundred day moving average price is $231.08. The company has a market cap of $182.64 billion, a P/E ratio of 41.77, a price-to-earnings-growth ratio of 3.78 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same quarter last year, the business earned $2.36 earnings per share. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. Sell-side analysts forecast that Danaher Co. will post 7.65 earnings per share for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were given a $0.27 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date was Wednesday, March 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is 18.31%.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research analyst reports. Robert W. Baird raised their price target on shares of Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a report on Wednesday. KeyCorp raised their price target on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Citigroup raised their target price on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Barclays raised their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $270.00.

Insider Activity

In other news, Director Teri List sold 3,289 shares of Danaher stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total value of $816,724.48. Following the sale, the director now owns 19,726 shares in the company, valued at $4,898,360.32. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director Teri List sold 3,289 shares of the business’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total transaction of $816,724.48. Following the transaction, the director now directly owns 19,726 shares in the company, valued at $4,898,360.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 4,000 shares of the business’s stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the transaction, the senior vice president now owns 29,830 shares in the company, valued at $7,457,798.30. The disclosure for this sale can be found here. Insiders have sold a total of 106,565 shares of company stock worth $26,641,364 over the last 90 days. 11.10% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.